PET Imaging of FSHR Expression in Tumors with (68)Ga-Labeled FSH1 Peptide

FSHR is an appealing target for cancer theranostics. Radiolabeled FSH1 and its derivatives have shown potential to in vivo detect FSHR expression. However, moderate labeling yields (~50% nondecay-corrected) may partially limit their wide use. (68)Ga is an excellent PET nuclide due to availability, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Donghui, Liu, Guifeng, Xu, Yuping, Wang, Yanting, Yue, Yuanyuan, Wang, Lizhen, Yan, Junjie, Wang, Xinyu, Yang, Runlin, Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612759/
https://www.ncbi.nlm.nih.gov/pubmed/29097913
http://dx.doi.org/10.1155/2017/2674502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612759/
https://www.ncbi.nlm.nih.gov/pubmed/29097913
http://dx.doi.org/10.1155/2017/2674502

Ejemplares similares